C81.76
Other Hodgkin lymphoma, intrapelvic lymph nodes
Clinical Classification Guidelines
Medical Intelligence & Overview
Hodgkin lymphoma is a type of cancer that originates in the lymphatic system. Specifically, it involves the growth of abnormal lymphocytes, which are vital components of the immune system. The subtype identified by ICD-10 Code C81.76 refers to Hodgkin lymphoma that primarily affects intrapelvic lymph nodes, the lymph nodes located within the pelvis. Recognizing this condition is important for timely diagnosis and treatment, which can significantly impact outcomes.
Causes & Symptoms
Clinical Causes: Genetic factors which may predispose some individuals to lymphoma Previous exposure to certain viruses, such as Epstein-Barr virus (EBV) Immunodeficiency conditions that weaken immune defenses Family history of Hodgkin lymphoma or other lymphoid cancers Environmental exposures, including certain chemicals or radiation Autoimmune diseases that alter immune function
Key Symptoms: Swelling or painless enlargement of lymph nodes in the pelvic area, which may be felt as a mass Persistent fatigue or weakness Unexplained weight loss Fever that may come and go Night sweats indicating possible systemic involvement Itching all over the body Discomfort or pain in the pelvic region, especially after drinking alcohol Symptoms related to pressure on surrounding organs, such as urinary or bowel issues
Diagnostic & Treatment
Diagnosis Path: Diagnosing Hodgkin lymphoma affecting intrapelvic lymph nodes typically involves multiple steps:
Treatment Protocols: Treatment strategies for Hodgkin lymphoma involving intrapelvic lymph nodes generally depend on the stage of the disease and the patient’s overall health:
Clinical Advice & FAQs
Billing Guidance
Is C81.76 a billable ICD-10 code?
Yes, C81.76 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report C81.76?
Clinical documentation must specify the nature of Other Hodgkin lymphoma, intrapelvic lymph nodes and any associated comorbidities for accurate reporting.
Cite this Clinical Reference
